Home › Asset managers › Vanguard › 2025-2026 › Against the board
At least 6,029 proposals in the 2025-2026 proxy season: Vanguard voted against, or withheld its votes from, at least 6,000 proposals put forward by company boards, and voted for 29 shareholder proposals, by its own Form N-PX filings.
Two kinds of vote are listed: a board-sponsored proposal Vanguard voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
6,029 proposals. The board-sponsored half of this list keeps the 6,000 proposals with the most funds behind them; the rest are in the interactive database. Every shareholder proposal it backed is listed in full.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Vanguard voted | Funds |
|---|---|---|---|---|---|---|---|
| Dallah Healthcare Co. | October 19, 2025 | Elect Fahd Al Qasim as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Faris Al Faris as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Faysal Al Abdulsalam as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Faysal Al Assaf as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Faysal bin Hameed as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Hamad Al Abdulateef as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Hani Qashlan as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Huseen Abou Saq as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Khalid Al Rayis as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Lateefah Al Sarhan as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Majid Al Baddah as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Majid Al Suweegh as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Majid Fattah as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Mohammed Al Faqeeh as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Mohammed Al Mutlaq as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Mohammed Al Qarni as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Mohammed Al Shihri as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Mohammed Al Sultan as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Mohammed Hafni as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Mohammed Hantoul as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Muhyi Al Deen Kamil as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Nasir Boursli as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Omar Abduljabbar as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Salih Al Qurayshah as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Saoud Al Arfaj as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Sarran Abou Saq as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Shabnam Mohammed as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Sulayman Al Omeeri as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Sultan Al Farawi as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Tariq Al Qasabi as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Tariq Al Saad as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Tariq Khoush Hal as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Thamir Al Wadee as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Usamah Al Zamil as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dallah Healthcare Co. | October 19, 2025 | Elect Ziyad Al Hazimi as Director | Director Elections | Board | ABSTAIN | 5 | |
| Dampskibsselskabet Norden A/S | March 11, 2026 | Approve Remuneration Report (Advisory Vote) | Compensation | Board | AGAINST | 5 | |
| Danel (Adir Yeoshua) Ltd. | December 10, 2025 | Reelect Racheli Magnezi as Director | Director Elections | Board | AGAINST | 5 | |
| Danel (Adir Yeoshua) Ltd. | December 10, 2025 | Reelect Tal Moshe Perluk as Director | Director Elections | Board | AGAINST | 5 | |
| Davide Campari-Milano NV | April 16, 2026 | Approve Remuneration Report | Compensation | Board | AGAINST | 5 | |
| Davide Campari-Milano NV | April 16, 2026 | Authorize Board to Repurchase Shares | Capital Structure | Board | AGAINST | 5 | |
| Dazhong Mining Co., Ltd. | July 14, 2025 | Amend the Principles of Bondholders Meeting | Capital Structure | Board | AGAINST | 5 | |
| Dazhong Mining Co., Ltd. | May 14, 2026 | Approve Estimated Amount of Guarantee for Subsidiary | Capital Structure | Board | AGAINST | 5 | |
| Deep Yellow Limited | November 20, 2025 | Approve Issuance of 2025 Loan Shares and Provision of Loan to John Borshoff | Compensation | Board | AGAINST | 5 | |
| Definitive Healthcare Corp. | June 4, 2026 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in this Proxy Statement. | Say-on-Pay | Board | AGAINST | 5 | |
| Delta Galil Industries Ltd. | October 27, 2025 | Reelect Richard Hunter as Director | Director Elections | Board | AGAINST | 5 | |
| Deutsche Beteiligungs AG | June 2, 2026 | Approve Remuneration Policy | Compensation | Board | AGAINST | 5 | |
| Deutsche Beteiligungs AG | June 2, 2026 | Approve Remuneration Report | Compensation | Board | AGAINST | 5 | |
| Devyani International Ltd. | March 8, 2026 | Approve Issuance of Non-Convertible Redeemable Preference Shares on Private Placement Basis | Capital Structure | Board | AGAINST | 5 | |
| Devyani International Ltd. | March 8, 2026 | Approve Reclassification of Authorized Share Capital and Amend Memorandum of Association | Capital Structure | Board | AGAINST | 5 | |
| Dingdong (Cayman) Limited | March 27, 2026 | Approve Sale and Purchase Agreement and Related Transactions | Extraordinary Transactions | Board | AGAINST | 5 | |
| Dingdong (Cayman) Limited | March 27, 2026 | Authorize Use of Proceeds | Capital Structure | Board | AGAINST | 5 | |
| Dis-Chem Pharmacies Ltd. | July 31, 2025 | Approve Remuneration Philosophy and Policy | Compensation | Board | AGAINST | 5 | |
| Dis-Chem Pharmacies Ltd. | July 31, 2025 | Place Authorised but Unissued Shares under Control of Directors | Capital Structure | Board | AGAINST | 5 | |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd. | January 9, 2026 | Approve Authorization of the Board of Directors and Its Authorized Persons to Handle All Related Matters | Capital Structure | Board | AGAINST | 5 | |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd. | January 9, 2026 | Approve Company's Issuance of H Shares and Listing on the Hong Kong Stock Exchange | Capital Structure | Board | AGAINST | 5 | |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd. | January 9, 2026 | Approve Fundraising Cost Analysis | Capital Structure | Board | AGAINST | 5 | |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd. | January 9, 2026 | Approve Issuance Method | Capital Structure | Board | AGAINST | 5 | |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd. | January 9, 2026 | Approve Issuance Scale | Capital Structure | Board | AGAINST | 5 | |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd. | January 9, 2026 | Approve Issuance and Listing Time | Capital Structure | Board | AGAINST | 5 | |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd. | January 9, 2026 | Approve Listing Location | Capital Structure | Board | AGAINST | 5 | |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd. | January 9, 2026 | Approve Offering Principles | Capital Structure | Board | AGAINST | 5 | |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd. | January 9, 2026 | Approve Pricing Method | Capital Structure | Board | AGAINST | 5 | |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd. | January 9, 2026 | Approve Profit Distribution Plan Prior to the Company's Issuance of H Shares | Capital Structure | Board | AGAINST | 5 | |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd. | January 9, 2026 | Approve Resolution Validity Period | Capital Structure | Board | AGAINST | 5 | |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd. | January 9, 2026 | Approve Target Subscribers | Capital Structure | Board | AGAINST | 5 | |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd. | January 9, 2026 | Approve Type and Par Value of Shares Issued | Capital Structure | Board | AGAINST | 5 | |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd. | January 9, 2026 | Approve Usage Plan of Raised Funds | Capital Structure | Board | AGAINST | 5 | |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd. | January 9, 2026 | Approve the Company's Registration as a Non-Hong Kong Company in Hong Kong, the Establishment of a Principal Address for Business in Hong Kong and the Appointment of an Authorized Person to Accept Service of Documents in Hong Kong | Capital Structure | Board | AGAINST | 5 | |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd. | January 9, 2026 | Approve to Appoint Auditor | Audit-related | Board | AGAINST | 5 | |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd. | April 20, 2026 | Approve 2026 Remuneration (Allowance) of Directors | Compensation | Board | AGAINST | 5 | |
| Do-Fluoride New Materials Co., Ltd. | December 29, 2025 | Approve Additional Guarantee | Capital Structure | Board | AGAINST | 5 | |
| Do-Fluoride New Materials Co., Ltd. | May 7, 2026 | Approve Application of Credit Lines | Capital Structure | Board | AGAINST | 5 | |
| Do-Fluoride New Materials Co., Ltd. | May 7, 2026 | Approve the Estimated Amount of External Guarantees | Capital Structure | Board | AGAINST | 5 | |
| Dogan Sirketler Grubu Holding AS | April 10, 2026 | Approve Director Remuneration | Compensation | Board | AGAINST | 5 | |
| Dogan Sirketler Grubu Holding AS | April 10, 2026 | Elect Directors | Director Elections | Board | AGAINST | 5 | |
| Dongfeng Automobile Co., Ltd. | October 30, 2025 | Amend Implementation Rules of the Remuneration Management Committee of the Board of Directors | Compensation | Board | AGAINST | 5 | |
| Dongjiang Environmental Company Limited | June 29, 2026 | Approve Application of Integrated Bank Credit Facilities | Capital Structure | Board | AGAINST | 5 | |
| Dynamic Holding Co., Ltd. | June 26, 2026 | Amend Procedures for Lending Funds to Other Parties | Extraordinary Transactions | Board | AGAINST | 5 | |
| E1 Corp. | March 27, 2026 | Elect Han Sang-hun as Inside Director | Director Elections | Board | AGAINST | 5 | |
| EFORT Intelligent Robot Co., Ltd. | December 17, 2025 | Approve to Formulate Management System for Remuneration of Directors and Senior Management | Compensation | Board | AGAINST | 5 | |
| ELECTRONIC ARTS INC. | December 22, 2025 | To consider and vote on a proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to the Company's named executive officers in connection with the transactions contemplated by the merger agreement, including consummation of the merger. | Compensation | Board | AGAINST | 5 | |
| ELGI Equipments Limited | August 12, 2025 | Reelect Sudarsan Varadaraj as Director | Director Elections | Board | AGAINST | 5 | |
| ENEA SA | May 28, 2026 | Approve Remuneration Report | Compensation | Board | AGAINST | 5 | |
| ENEA SA | May 28, 2026 | Elect Supervisory Board Chair | Director Elections | Board | AGAINST | 5 | |
| ENGIE Brasil Energia SA | April 24, 2026 | Approve Remuneration of Company's Management | Compensation | Board | AGAINST | 5 | |
| ENGIE Brasil Energia SA | April 24, 2026 | Elect Directors | Director Elections | Board | AGAINST | 5 | |
| ENGIE Brasil Energia SA | April 24, 2026 | Elect Mauricio Stolle Bahr as Board Chair | Director Elections | Board | AGAINST | 5 | |
| ENGIE Brasil Energia SA | April 24, 2026 | Elect Paulo Jorge Tavares Almirante as Board Vice-Chair | Director Elections | Board | AGAINST | 5 | |
| ENGIE Brasil Energia SA | April 24, 2026 | In Case Cumulative Voting Is Adopted, Do You Wish to Equally Distribute Your Votes Amongst the Nominees below? | Director Elections | Board | ABSTAIN | 5 | |
| ENGIE Brasil Energia SA | April 24, 2026 | Percentage of Votes to Be Assigned - Elect Carlos Alberto Vieira as Director and Marcos Roberto Castanheira as Alternate | Director Elections | Board | ABSTAIN | 5 | |
| ENGIE Brasil Energia SA | April 24, 2026 | Percentage of Votes to Be Assigned - Elect Gil de Methodio Maranhao Neto as Director and Marcio Daian Neves as Alternate | Director Elections | Board | ABSTAIN | 5 | |
| ENGIE Brasil Energia SA | April 24, 2026 | Percentage of Votes to Be Assigned - Elect Karin Koogan Breitman as Independent Director and Maria Claudia Guimaraes as Alternate | Director Elections | Board | ABSTAIN | 5 | |
| ENGIE Brasil Energia SA | April 24, 2026 | Percentage of Votes to Be Assigned - Elect Manoel Eduardo Lima Lopes as Independent Director and Raquel da Fonseca Cantarino as Alternate | Director Elections | Board | ABSTAIN | 5 | |
| ENGIE Brasil Energia SA | April 24, 2026 | Percentage of Votes to Be Assigned - Elect Mauricio Stolle Bahr as Director and Eduardo Antonio Gori Sattamini as Alternate | Director Elections | Board | ABSTAIN | 5 | |
| ENGIE Brasil Energia SA | April 24, 2026 | Percentage of Votes to Be Assigned - Elect Paulo Jorge Tavares Almirante as Director and Sylvie Marie Vicente ep. Credot as Alternate | Director Elections | Board | ABSTAIN | 5 | |
| ENGIE Brasil Energia SA | April 24, 2026 | Percentage of Votes to Be Assigned - Elect Paulo Mauricio Mantuano de Lima as Independent Director and Antonio Alberto Gouvea Vieira as Alternate | Director Elections | Board | ABSTAIN | 5 | |
| ENGIE Brasil Energia SA | April 24, 2026 | Percentage of Votes to Be Assigned - Elect Pierre Jean Bernard Guillot as Director and Pierre Auguste Gratien Leblanc as Alternate | Director Elections | Board | ABSTAIN | 5 | |
| ENGIE Brasil Energia SA | April 24, 2026 | Percentage of Votes to Be Assigned - Elect Sophie Brigitte Quarre de Verneuil as Director and Gustavo Henrique Labanca Novo as Alternate | Director Elections | Board | ABSTAIN | 5 | |
| ENOVIS CORPORATION | May 19, 2026 | Election of Director: A. Clayton Perfall | Director Elections | Board | AGAINST | 5 | |
| ENOVIS CORPORATION | May 19, 2026 | Election of Director: Angela S. Lalor | Director Elections | Board | AGAINST | 5 |
← Previous Page 49 of 61 Next →
← Back to Vanguard 2025-2026 overview
Built November 7, 2026 from SEC Form N-PX filings.